StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > The COC Protocol Has All New Features!

<< Previous

Bullboard Posts

Next >>

Comment by IainCaimbeulon Feb 16, 2023 9:17pm

56 Views

Post# 35291265

RE:The COC Protocol Has All New Features!

Share price mon ami

Nailbiter2 wrote:
In addition to targeting cancer metabolism through medications, our protocol has evolved to provide you with nutrition and lifestyle recommendations informed by advanced biomarker testing to help you optimize your metabolic and inflammatory health. We'll provide guidance on nutrition, supplements, exercise, sleep and stress management, all of which play a crucial role in keeping you healthy. And we’re excited to introduce our new digital health platform - COC Health Insights. Now you can see your progress on the COC Protocol through our new dynamic health report!